Skip to content

The safety and effectiveness of triamcinolone acetonide-filling and oral prednisone method in preventing stenosis after extensive esophageal endoscopic submucosal dissection

The safety and effectiveness of triamcinolone acetonide-filling and oral prednisone method in preventing stenosis after extensive esophageal endoscopic submucosal dissection

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200064569
Enrollment
Unknown
Registered
2022-10-12
Start date
2022-10-10
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal superficial cancer and precancerous lesion

Interventions

Group 1 :TA-filling and oral prednisone
Group 2:endoscopic TA local injection and oral prednisone

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Superficial esophageal cancer and precancerous lesions diagnosed by white light endoscopy + electronic chromoendoscopy, biopsy pathology, and endoscopic ultrasound; 2. A single lesion is expected to reach 3/4 or more of the esophageal circumference after resection, or multiple lesions are at the same level and the expected horizontal range of the wounds after resection reaches 3/4 or more of the esophageal circumference; 3. The length of the wound reaches 3 cm or more; 4. Preoperative CT excluded lymph nodes and distant metastasis.

Exclusion criteria

Exclusion criteria: 1. Previously received endoscopic or other recurrent lesions on the basis of treatment; 2. There are contraindications to anesthesia, ESD treatment or application of glucocorticoids; 3. Combined with swallowing dysfunction, severe head, neck and chest infection and other basic diseases; 4. The muscularis propria of the esophagus is obviously damaged or perforated during ESD; 5. Patients undergoing surgery for endoscopic non-curative resection prior to complete epithelialization of the wound.

Design outcomes

Primary

MeasureTime frame
incidence of stenosis;

Secondary

MeasureTime frame
total number of additional TA-filling procedures;time to initial stenosis;time to complete re-epithelialization without stenosis;dysphagia score;total number of endoscopic balloon/bougie dilatation procedures;

Countries

China

Contacts

Public ContactLong Rong

Peking University First Hospital

ronglong8@vip.sina.com+86 10 83572437

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026